Beam stock forecast.

Beam Therapeutics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... We provide commentary based on historical data and analyst forecasts ...The upgrade of Beam Therapeutics Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global, the second EV charging ...Beam Global analyst ratings, historical stock prices, earnings estimates & actuals. BEEM updated stock price target summary.

The Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago.$-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend …Beam Therapeutics (BEAM) Stock Price, News & Analysis $29.47 +1.52 (+5.44%) (As of 05:07 PM ET) Compare Today's Range $28.28 $29.84 50-Day Range $17.69 $30.76 52-Week Range $16.95 $51.60 Volume 1.35 million shs Average Volume 986,767 shs Market Capitalization $2.40 billion P/E Ratio N/A Dividend Yield N/A Price Target $48.80

This morning Beam, an insurtech startup that provides dental coverage to corporate employees, announced that it has closed an $80 million Series E. Mercato-affiliated Traverse led the investment, with Nationwide insurance joining the deal. ...

(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...$-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23)...John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ...Lead the world to clean mobility. We believe every person deserves access to safe, clean, reliable transportation. BEAM’s 100% sustainable EV charging solutions are the most rapidly deployed EV charging stations in the world. Fastest Deployed EV Charging In Action.

When builders want to create something sturdy and attractive, like a bridge that spans a large river or a tall skyscraper, they must rely on structural steel. Made up mostly of beams, structural steel comes in dozens of standard beam sizes....

For Beam Global stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Beam Global stock forecast of $6.11, a high forecast of $6.11, and a low forecast of $6.11. The average Beam Global stock forecast 2023 represents a 4.43% increase from the last price of $5.84999990463257. For Beam Global stock forecast for ...

Inflation and geopolitical conflicts remain risks for investors. The stock market is entering the end of 2023 with major positive momentum, including an eight-day winning streak for the S&P 500 in ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Taiwan Semiconductor Manufacturing Co Ltd have a median target of 115.00, with a high estimate of 130.00 and a low ...Inflation and geopolitical conflicts remain risks for investors. The stock market is entering the end of 2023 with major positive momentum, including an eight-day winning streak for the S&P 500 in ...Beam Global Stock Price, News & Analysis (NASDAQ:BEEM) $6.02 -0.12 (-1.95%) (As of 11/29/2023 ET) Compare Today's Range $6.01 $6.57 50-Day Range $5.35 …Based on those assumptions, my modeling says Aeva could do about $10 in earnings per share by 2030. A simple 20X multiple on that implies a long-term potential price target here of $200. The AEVA ...

3 Wall Street research analysts have issued 12-month price targets for Beam Global's shares. Their BEEM share price targets range from $25.00 to $25.00. On average, they anticipate the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 315.3% from the stock's current price.Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -8.44M. -19.71%. Get the latest Beam Global (BEEM) real-time quote ... Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...Stock Forecast Based On a Predictive Algorithm | I Know First | Disclaimer: I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage diagnostics company that provides care for transplant patients, from finding the right match to follow-on surveillance post-transplant.

Fiscal Q3 2023 ended 9/30/23. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading... Stock Price Forecast The 3 analysts offering 12-month price forecasts for Velo3D Inc have a median target of 2.00, with a high estimate of 2.10 and a low estimate of 1.48.

The average Beam Therapeutics stock price prediction forecasts a potential upside of 52.06% from the current BEAM share price of $27.95. What is BEAM's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BEAM ) forecast ROE is N/A , which is considered weak .Apr 20, 2023 · Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ... John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ...Analyst Forecast. According to 9 analysts, the average rating for BEAM stock is "Buy." The 12-month stock price forecast is $55.22, which is an increase of …Fiscal Q3 2023 ended 9/30/23. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading... In the field of construction, the use of steel beams is vital for providing structural support and stability to buildings. When it comes to steel beams, using standardized sizes has numerous benefits.Nov 22, 2023 · The Beam Therapeutics Inc. stock price gained 5.44% on the last trading day (Wednesday, 22nd Nov 2023), rising from $27.95 to $29.47. During the last trading day the stock fluctuated 5.68% from a day low at $28.24 to a day high of $29.84. The price has been going up and down for this period, and there has been a 28.69% gain for the last 2 weeks. Real Money Technical Analyst Bruce Kamich gives his updated 2023 market forecast Employees of theStreet are prohibited from trading individual securities. Here's how traders can play this biotech stock. The charts of the building materials ...

Stock Splits: Mergers & Acquisitions: Business Services/Equipment M&A Construction M&A General Contractors & Builders M&A Consumer Goods M&A Sporting Goods & Activities M&A Office Supplies M&A Food & Beverage M&A Beverages & Wineries M&A Cigarettes & Tobacco M&A Marijuana Stocks M&A Apparel Stores M&A Department Stores M&A …

Nov 29, 2023 · The Beam Global stock price fell by -1.95% on the last day (Wednesday, 29th Nov 2023) from $6.14 to $6.02. During the last trading day the stock fluctuated 9.27% from a day low at $6.01 to a day high of $6.57. The price has fallen in 7 of the last 10 days and is down by -17.53% for this period. Volume fell on the last day along with the stock ...

Meta Platforms Inc. () Stock Market info Recommendations: Buy or sell Meta Platforms stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Meta Platforms share forecasts, stock quote and buy / sell signals below.According to present data Meta Platforms's META shares and potentially its market environment have …Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. EXAS Stock 12 Months Forecast. $95.46. (50.43% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Exact Sciences in the last 3 months. The average price target is $95.46 with a high forecast of $120.00 and a low forecast of $80.00. The average price target represents a 50.43% change from the last price of $63.46.BEAM stock, the ticker symbol for Beam Therapeutics Inc, experienced a significant increase in its price on October 19, 2023. According to data from CNN Money, 14 analysts have provided 12-month price forecasts for the stock. The median target price is $61.00, with a high estimate of $105.00 and a low estimate of $27.00.(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...Motley Fool Issues Rare Triple-Buy Alert. This Stock Could Be Like Buying Amazon for $3.19. Find real-time Symbol not found stock quotes, company profile, news and forecasts from CNN Business.NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25. Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Nintendo Co Ltd have a median target of 46.72, with a high estimate of 59.00 and a low estimate of 31.78. The median ...Nov 22, 2023 · The Beam Therapeutics Inc. stock price gained 5.44% on the last trading day (Wednesday, 22nd Nov 2023), rising from $27.95 to $29.47. During the last trading day the stock fluctuated 5.68% from a day low at $28.24 to a day high of $29.84. The price has been going up and down for this period, and there has been a 28.69% gain for the last 2 weeks. Beam Therapeutics Stock Chart and Share Price Forecast, Short-Term "BEAM" Stock Prediction for Next Days and Weeks Walletinvestor.com Beam Therapeutics Inc (BEAM) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 Term Box: Best Beam forecast, Beam price prediction, Beam coin forecast, Beam finance tips, Beam cryptocurrency prediction, BEAM analyst report, Beam price predictions 2023, BEAM currency forecast, Beam forecast tomorrow, Beam technical analysis, Beam coin future price, BEAM projections, Beam market prognosis, Beam expected price.

Lead the world to clean mobility. We believe every person deserves access to safe, clean, reliable transportation. BEAM’s 100% sustainable EV charging solutions are the most rapidly deployed EV charging stations in the world. Fastest Deployed EV Charging In Action.AUPH Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $14.20 with a high forecast of $15.00 and a low forecast of $13.00. The average price target represents a 71.29% change from the last price of $8.29.GLBE Stock 12 Months Forecast. $46.11. (31.33% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Global-e Online in the last 3 months. The average price target is $46.11 with a high forecast of $50.00 and a low forecast of $41.00. The average price target represents a 31.33% change from the last price of $35.11.Instagram:https://instagram. current rate i bondsgood renewable energy stockscan u pre order the iphone 15faang stocks Nov 30, 2023 · Beam Therapeutics Inc. (BEAM) Stock Price, Quote & News - Stock Analysis 29.67 +0.20 (0.68%) At close: Nov 24, 2023, 1:00 PM 30.22 +0.55 (1.85%) After-hours: Nov 24, 2023, 4:42 PM EST Overview Financials Statistics Profile Chart 1Y Max 0.68% ( 1D) About BEAM In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business. best mortgage lenders nashville tnemini scalping strategy Oct 15, 2020 · The Beam Therapeutics stock forecast is 57.069107374265 USD for 2024 November 25, Monday; and 177.367 USD for 2028 November 25, Saturday with technical analysis. Beam Therapeutics (BEAM) stock price prediction is 57.069107374265 USD. qualcomm stock prediction On today's stock market, VERV stock soared 28% to 12.04. Beam stock surged 10.6% to 21.14. Beam stock surged 10.6% to 21.14. Eli Lilly stock , on the other hand, skidded 2.1% to 553.93.The Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago.